Old Mission Capital LLC Calliditas Therapeutics Ab Transaction History

Old Mission Capital LLC

  • $3.85 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$11.5 - $19.6 $540 - $921
47 New
47 $0
Q2 2021

Aug 13, 2021
SELL
$26.02 - $31.17 $472,158 - $565,610
-18,146 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$27.01 - $32.92 $490,123 - $597,366
18,146 New
18,146 $500,000
Q3 2020

Nov 16, 2020
SELL
$21.61 - $25.69 $188,957 - $224,633
-8,744 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$19.17 - $23.2 $167,622 - $202,860
8,744 New
8,744 $203,000

Others Institutions Holding CALT

# of Institutions
24
Shares Held
871K
Call Options Held
1.5K
Put Options Held
32.4K
View Full List

About Calliditas Therapeutics AB

CALT Quotes by TradingView
  • Ticker CALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,624,800
  • Market Cap $1.03B
  • Description
  • Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...
More about CALT
Track This Portfolio

Track Old Mission Capital LLC Portfolio

Follow Old Mission Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Mission Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email